Situation: A 68-year-old man with chronic obstructive pulmonary disease (COPD) and a 45 pack-year smoking history is admitted to the medical ward with an exacerbation: 3 days of increased breathlessness and more purulent sputum. His records show chronic carbon dioxide retention. On room air, his oxygen saturation by pulse oximetry (SpO2) is 84%. Before discharge, while stable and resting on room air, his results are: arterial oxygen tension (PaO2) 57 mmHg, arterial oxygen saturation 89%, and hematocrit 58%. He has no ankle edema. He asks whether he will need oxygen at home. Which response by the nurse is accurate?

Long-term oxygen therapy is indicated for a resting PaO2 of 55 mmHg or less (or saturation of 88% or less), or for a PaO2 of 55 to 60 mmHg when there is pulmonary hypertension, cor pulmonale or edema, or polycythemia with hematocrit above 55%. His PaO2 of 57 mmHg with a hematocrit of 58% meets the second criterion, and oxygen is used at least 15 hours a day because that improves survival, and he will be reassessed 60 to 90 days after starting.

Why this patient qualifies for home oxygen

The patient’s resting arterial oxygen tension (PaO2) is 57 mmHg, which by itself is not low enough to meet the classic threshold of 55 mmHg or less. However, long-term oxygen therapy (LTOT) is also indicated when the PaO2 falls between 56 and 59 mmHg and the patient has evidence of end-organ consequences of chronic hypoxemia. In this case, the hematocrit is 58%, which exceeds the 55% cutoff used to define secondary polycythemia. A PaO2 of 57 mmHg combined with a hematocrit above 55% satisfies the second LTOT criterion, so home oxygen is appropriate.

The rationale for this secondary criterion is that chronic hypoxemia drives excessive erythropoietin production, raising red cell mass and blood viscosity. A hematocrit above 55% signals that the body is mounting a compensatory polycythemic response to prolonged tissue hypoxia. Treating the underlying hypoxemia with supplemental oxygen reduces this stimulus and lowers the risk of complications such as pulmonary hypertension and cor pulmonale ^[1][2].

Key point! The threshold of 55 mmHg is not the only qualifying PaO2. The range of 56 to 59 mmHg also qualifies when accompanied by cor pulmonale, pulmonary hypertension, dependent edema, or a hematocrit greater than 55% ^[1][3].

Why at least 15 hours per day

The landmark NOTT and MRC trials demonstrated that survival benefit in COPD patients receiving LTOT was observed specifically in those who used oxygen for more than 15 hours per day ^[1][3]. Longer daily use, approaching 24 hours, is generally preferred when tolerated, but 15 hours is the minimum duration associated with improved mortality ^[3][4]. The nurse should explain that oxygen must be used consistently for at least 15 hours each day, including during sleep, because nocturnal hypoventilation and REM-related desaturation are common in COPD.

Watch out! Option 2 mentions oxygen only during sleep and walking. While exertional and nocturnal desaturation may occur, LTOT is prescribed based on resting hypoxemia criteria, not solely on activity-related drops. The qualifying result here is the resting PaO2 plus elevated hematocrit, and the prescription is continuous daily use, not intermittent use tied only to specific activities ^[1][4].

Why options 1 and 4 are incorrect

Option 1 states that home oxygen starts only when arterial oxygen is 55 mmHg or less. This ignores the secondary criterion that extends eligibility to PaO2 values of 56 to 59 mmHg when signs of chronic hypoxemia such as polycythemia are present ^[1][2]. Option 4 focuses on the oxygen saturation of 89%, which is above the 88% cutoff. However, the arterial blood gas PaO2 and the hematocrit are the deciding factors here, not the pulse oximetry value alone. A saturation above 88% does not exclude LTOT when the PaO2 and hematocrit meet the expanded criteria.

LTOT indication	Criteria	This patient
Severe resting hypoxemia	PaO2 55 mmHg or less (or SaO2 88% or less)	PaO2 57 mmHg — does not meet this alone
Moderate hypoxemia with complications	PaO2 56 to 59 mmHg plus cor pulmonale, pulmonary hypertension, edema, or hematocrit greater than 55%	Hematocrit 58% — meets this criterion

The patient should also be reassessed approximately 60 to 90 days after starting LTOT to confirm continued need and evaluate adherence and response ^[1][2].